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ABSTRACT
Seasonal influenza virus infections cause annual epidemics and
sporadic pandemics. These present a global health concern, resulting
in substantial morbidity, mortality and economic burdens. Prevention
and treatment of influenza illness is difficult due to the high mutation
rate of the virus, the emergence of new virus strains and increasing
antiviral resistance. Animal models of influenza infection are crucial to
our gaining a better understanding of the pathogenesis of and host
response to influenza infection, and for screening antiviral compounds.
However, the current animal models used for influenza research are
not amenable to visualization of host-pathogen interactions or high-
throughput drug screening. The zebrafish is widely recognized as a
valuable model system for infectious disease research and therapeutic
drug testing. Here, we describe a zebrafish model for human influenza
A virus (IAV) infection and show that zebrafish embryos are susceptible
to challenge with both influenza A strains APR8 and X-31 (Aichi).
Influenza-infected zebrafish show an increase in viral burden and
mortality over time. The expression of innate antiviral genes, the gross
pathology and the histopathology in infected zebrafish recapitulate
clinical symptoms of influenza infections in humans. This is the first
time that zebrafish embryos have been infected with a fluorescent IAV
in order to visualize infection in a live vertebrate host, revealing a
pattern of vascular endothelial infection. Treatment of infected
zebrafish with a known anti-influenza compound, Zanamivir, reduced
mortality and the expression of a fluorescent viral gene product,
demonstrating the validity of this model to screen for potential antiviral
drugs. The zebrafish model system has provided invaluable insights
into host-pathogen interactions for a range of infectious diseases.
Here, we demonstrate a novel use of this species for IAV research.
This model has great potential to advance our understanding of
influenza infection and the associated host innate immune response.
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INTRODUCTION
Influenza virus infections lead to substantial illness, mortality and
social disruption worldwide. In the United States alone, seasonal
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influenza is associated with an estimated 95,000-172,000
hospitalizations and 21,000-41,000 deaths, costing billions of dollars
in healthcare expenses annually (Lowen et al., 2006). Influenza
infections initially occur in epithelial cells of the respiratory tract and
can become systemic, potentially resulting in multi-organ failure and
death. Influenza A virus (IAV) is the most extensively studied type of
influenza virus because of the threat of a pandemic outbreak. New
strains of IAV with altered pathogenicity and/or antiviral resistance
emerge with high frequency due to the segmented, single-stranded
RNA genome of IAV, which allows for both antigenic drift and
antigenic shift (Medina and García-Sastre, 2011). Vaccines against
specific viral antigens are used in an attempt to provide hosts with
immunity to IAV. However, the constantly changing genome of
influenza A viruses makes it problematic to prevent or treat influenza-
mediated diseases through targeting the virus itself. A better
understanding of the host’s innate antiviral response to IAV could
elucidate new targets for antiviral medicines or adjuvant therapies.
Animal models of influenza infection are necessary to study
influenza pathogenesis and the host response to IAV. Several models
of IAV infection exist, each with unique advantages and limitations.
The hallmarks for such models are: susceptibility to influenza
infection, support of viral replication and recapitulation of clinical
symptoms of human disease. The current mammalian species used for
IAV research, such as mice, ferrets or macaques (Bouvier and Lowen,
2010), are invaluable for studies on transmission, adaptive immunity
and vaccine development. The development of a model in which
large-scale chemical and genetic screens can be conducted will
complement existing avenues of IAV research. We sought to use the
zebrafish (Danio rerio) as an alternative vertebrate animal model for
influenza infection studies because early-life stage zebrafish are highly
amenable to genetic manipulation, transgenesis and high-throughput
drug testing. An additional advantage of this model system is that
zebrafish rely solely on their innate immune response for the first 4-
6 weeks of development (Lam et al., 2004; Trede et al., 2004; Meeker
and Trede, 2008; Kanther and Rawls, 2010). Because a robust innate
immune response potentiates a subsequent heightened adaptive
immune response, zebrafish embryos provide an opportunity to study
the initial infection events to which the innate immune system
responds, independently of adaptive immunity. New targets for
antiviral drugs or adjuvant therapies could come from zebrafish
studies of the host’s innate immune response to IAV.
Zebrafish models of infectious diseases are well established.
Bacterial, fungal and viral infections have been characterized in
zebrafish (reviewed in Trede et al., 2004; van der Sar et al., 2004;
Sullivan and Kim, 2008; Tobin and Ramakrishnan, 2008; Lieschke
and Trede, 2009; Tobin et al., 2012). To date, studies of viral
pathogens that can infect and cause disease in zebrafish have been
limited primarily to fish-specific viruses (LaPatra et al., 2000;
Sanders et al., 2003; Phelan et al., 2005; Novoa et al., 2006; Lu et
al., 2008; Xu et al., 2008; Encinas et al., 2010; Gabor et al., 2013).
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Recent studies have now shown that zebrafish can be infected with
mammalian and/or human viruses. Adult zebrafish have been
infected with herpes simplex virus type 1 (Burgos et al., 2008), and
zebrafish larvae have been shown to support Chikungunya virus
infection (Palha et al., 2013).
Here, the zebrafish is established as a useful animal model for
studying human IAV infection. The sialic acid linkages known to
bind to human IAV were identified in zebrafish embryos, and
infection studies using two strains of IAV demonstrated that viral
burden and mortality increased over time. Cytokine profiling
revealed that an antiviral state was induced in IAV-infected
zebrafish, as it is in humans. Several aspects of gross pathologic and
histopathological findings, such as edema and tissue necrosis, were
similar between infected zebrafish and human IAV infections. A
genetically modified fluorescent reporter strain of IAV (NS1-GFP)
(Manicassamy et al., 2010) was utilized to visualize infection in a
transparent vertebrate host. Finally, an antiviral compound used to
treat IAV infection in humans reduced the mortality and observed
viral burden in IAV-infected zebrafish. Herein, the first studies
establishing the zebrafish as a model for human influenza infection
are presented, and it is shown that IAV infection proceeds and can
be resolved through similar mechanisms in zebrafish and humans.
RESULTS
α-2,6-linked sialic acids are present in zebrafish embryos
In order for cellular entry to occur, the IAV hemagglutinin protein
binds to host cell surface receptors containing terminal sialic acid
residues (Gottschalk, 1959). Human IAV isolates have a higher
affinity for terminal α-2,6-linked sialic acid-containing receptors
than other sialic acid linkages (Skehel and Wiley, 2000). It has been
demonstrated that zebrafish synthesize a variety of sialylated
glycoconjugates during the early stages of development and α-2,6-
linked sialic acids have been predicted to occur in zebrafish embryos
(Marx et al., 2001; Chang et al., 2010; Dehnert et al., 2012;
Langhauser et al., 2012; Schaper et al., 2012). In order to confirm
the presence of α-2,6-linked sialic acids, the specific sialic acid
linkages in wild-type zebrafish embryos at 48 hours post fertilization
(hpf), were identified using anion-exchange chromatography. Both
N-acetylneuraminic acid (NANA) and N-glycolylneuraminic acid
(NGNA) were detected in zebrafish embryos (supplementary
material Table S1).
The abundance of specific sialic acid linkages (i.e. α-2,6 and α-
2,3) was quantified, and Table 1 shows the detection of α-2,6-linked
sialic acids in zebrafish embryos (see also supplementary material
Fig. S1). Analysis of the sialic acids revealed no detectable α-2,3-
linked sialic acids in the same embryo samples (Table 1). These
results show that sialic acids with α-2,6 linkages are present in
zebrafish embryos and that human IAV isolates should be able to
attach to, and potentially enter, zebrafish embryo cells.
IAV replicates in and kills infected zebrafish
To determine whether human isolates of IAV can cause disease in
zebrafish embryos, zebrafish were injected with different strains of
influenza virus [APR8 (H1N1) or X-31 (H3N2)] or sterile PBS.
Approximately 5×103 units of the 50 percent egg infectious dose
(EID50) of IAV was injected intravenously at 48 hpf via the Duct of
Cuvier (DC) to model influenza viremia. Mortality was monitored
over a 5-day period and began at 24 hours post infection (hpi)
(Fig. 1A). Embryos injected with APR8 or X-31 showed a
cumulative mortality of 54% and 59%, respectively, whereas over
90% of the fish injected with PBS alone survived.
Viral burden was quantified from 24-96 hpi using 50 percent
tissue culture infective dose (TCID50) assays in order to demonstrate
replication of human IAV in zebrafish and to determine whether
death in IAV-infected zebrafish correlated with viral burden. Viral
burden was determined and revealed that embryos infected with
APR8 were initially injected with 2.55×102 TCID50/ml, and that this
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TRANSLATIONAL IMPACT
Clinical Issue
Influenza A virus (IAV) is a pathogen that poses a significant risk to
human health. The emergence of new strains of IAV with altered
virulence and increasing antiviral resistance are major clinical concerns.
The high frequency of occurrence, the potential for global pandemics
and the economic burden of influenza infection warrant the need for a
better understanding of influenza pathogenesis and the host response
so that new antiviral medicines can be developed. Model organisms are
crucial for testing the safety and efficacy of potential therapeutics, but to
date there has been no animal model of influenza infection in which
high-throughput chemical screens could be conducted.
Results
In this study, it is demonstrated that zebrafish embryos can be infected
with human isolates of IAV. A model of influenza viremia was generated
by injecting IAV into the bloodstream of zebrafish embryos at 2 days post
fertilization (dpf). An influenza infection of the respiratory tract was
recapitulated by injecting IAV into the swimbladder of 5-dpf larvae
because the swimbladder is considered to be anatomically and
functionally analogous to the mammalian lung. Upon challenge with IAV,
survival was reduced compared with uninfected controls, and viral
burden was detected in infected zebrafish. IAV-infected zebrafish
displayed heightened innate immune responses, as indicated by
increased expression of innate antiviral genes (ifnφ1 and mxa). Gross
pathology and histopathology revealed symptoms similar to human
influenza infections, including edema and tissue destruction. The use of
a fluorescent reporter strain of IAV enabled visualization of IAV infection
in vivo, demonstrating the potential for studies of host-pathogen
interactions in real time. Finally, treatment of infected zebrafish with an
established IAV antiviral ameliorated mortality, as well as viral replication
and burden (i.e. GFP expression of the fluorescent reporter strain of
IAV).
Implications and future directions 
The results presented in this work show that the mechanisms of
influenza infection are similar in humans and zebrafish, thus validating
the therapeutic efficacy of this model. The advantages of zebrafish
embryos were exploited to visualize IAV infection in vivo and to rapidly
confirm the antiviral activity of a known anti-influenza compound. The
use of the zebrafish embryo model for infectious disease studies
provides the opportunity for future studies involving 4D imaging, genetic
screening and high-throughput drug discovery. These future studies
have the potential to enhance our understanding of influenza infection
and of the establishment of the antiviral state. Ultimately, this new animal
model of IAV infection could lead to the identification of drug targets for
therapeutic intervention of IAV in humans.
Table 1. Identification of α-2,6-linked sialic acids in zebrafish
embryos
Total sialic acid content1
Sialic acid Analyte n mol μg
2,3-linked NANA n.d. –
NGNA n.d. –
2,6-linked NANA 0.5580 0.1726
NGNA 0.1318 0.0429
Summary of chromatogram data from the determination of 2,3- and 2,6-
linked sialic acids. The results showed that that 2,3-linked sialic acids were
not detected, suggesting that all sialic acids were probably attached to the
oligosaccharides through 2,6-linkages. 1The sample amount used for the
experiment was ~4.16 mg. n.d., not determined. D
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increased to 4.34×103 TCID50/ml at 96 hpi. Similarly, embryos
infected with X-31 had an initial viral titer of 2.80×102 TCID50/ml,
which increased to 2.66×103 TCID50/ml at 96 hpi (Fig. 1B). The
titers of both strains of IAV increased ~10-fold in infected zebrafish
over 96 hours. Taken together, these results show that IAV can
replicate in zebrafish and cause a systemic infection that leads to
mortality in a zebrafish host.
Antiviral genes are expressed in zebrafish infected with IAV
The use of animal models to study influenza infection allows for not
only virological assays, but also the reciprocal host response to IAV.
A better understanding of the host’s innate antiviral defenses against
IAV could lead to new targets for antivirals or adjuvant therapies.
Although zebrafish have both innate and adaptive immunity,
embryos and larvae rely on the innate immune response for the first
4-6 weeks of development. This temporal separation of innate and
adaptive immunity in zebrafish allows for the study of the innate
immune response to viral infection independent of adaptive
immunity. One of the host’s first innate immune responses to viral
attack is the induction of an antiviral state, which limits the spread
of infection. Interferon (IFN) is a crucial antiviral signaling molecule
and an indicator of the host antiviral state. Induction of IFN also
leads to the expression of Mx, a member of the GTPase protein
family, which was first recognized for its expression during the
antiviral response against IAV (Lindenmann, 1962). Zebrafish IFN
and IFN receptors have been previously characterized, and this
manuscript uses the IFNΦ nomenclature suggested by the authors
(Levraud et al., 2007; Aggad et al., 2009). To determine whether
antiviral signaling cascades are induced in a manner similar to that
of mammals, zebrafish were infected with IAV through DC
injection, and mRNA expression levels of ifnφ1 and mxa were
measured in control and IAV-infected zebrafish samples by using
quantitative PCR (qPCR) at 24, 48 and 72 hpi. qPCR analyses
demonstrated that infection with APR8 caused ifnφ1 expression to
increase within the first 24 hpi, peak at 48 hpi and remain elevated
for 72 hpi compared with uninfected controls (Fig. 2A). Zebrafish
infected with X-31 exhibited an ifnφ1 expression profile similar to
that of APR8-infected zebrafish (Fig. 2B). These data clearly
demonstrate that IAV infection induces ifnφ1 expression in
zebrafish.
Induction of mxa expression was also observed in IAV-infected
zebrafish. Infection with APR8 resulted in a steady increase in mxa
expression through to 72 hpi, relative to uninfected controls
(Fig. 2C). Infection with X-31 led to increased mxa expression that
peaked at 48 hpi, but remained elevated through to 72 hpi (Fig. 2D).
These results demonstrate that IAV infection also induces mxa
expression in zebrafish. It has been reported that the NS1 gene of
IAV has the ability to interfere with IFN expression and to function
through multiple mechanisms (Hale et al., 2008); however, IFN and
downstream targets of IFN signaling are still commonly shown to
be induced upon IAV infection (García-Sastre, 2002; García-Sastre,
2011). Taken together, these cytokine profiles show that zebrafish
initiate an antiviral state in response to IAV infection through
antiviral signaling cascades that are conserved in mammals.
Systemic IAV infection in zebrafish causes a pathological
phenotype
To further characterize the zebrafish innate immune response to IAV
viremia, infected embryos were monitored over time for phenotypic
and behavioral changes. PBS-injected controls did not display
abnormal behaviors or signs of infection over time (Fig. 3A,C,E).
However, zebrafish infected with either strain of IAV were lethargic
by 24 hpi (data not shown). Edema was commonly observed in the
pericardium (Fig. 3B,D,F) and yolk sac (Fig. 3B,D,F) of IAV
infected embryos. The edema observed in infected zebrafish
worsened over time. Moreover, other pathological phenotypes were
observed in IAV-infected zebrafish, including varying degrees of
lordotic bending of the spine (Fig. 3F), pigmentation defects, eye
abnormalities and craniofacial deformities (Fig. 3D, red arrowhead).
For additional investigation of pathophysiology, histopathology
sections were prepared from zebrafish with IAV viremia at 48 hpi.
Histopathological analyses confirmed the presence of clinical
symptoms of influenza, including necrotic tissues and edema
(Taubenberger and Morens, 2008). Neither tissue degeneration nor
edema was apparent in PBS-injected zebrafish (Fig. 4A-D). In
APR8-infected fish, necrotic degeneration of liver and gill tissues
was observed (Fig. 4F,G). Necrotic cells in the hematopoietic tissue
of the head kidney were evident in X-31-infected fish (Fig. 4J).
Histopathology confirmed that pericardial edema occurred in APR8-
infected zebrafish (Fig. 4H) and not in PBS-injected fish (Fig. 4D).
Foci of accumulated granulocytes or monocytes in virus-infected
fish were not observed, suggesting widespread dissemination of the
1229
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Fig. 1. Zebrafish embryos are susceptible to IAV infection, and IAV
replicates in zebrafish hosts. PBS- or IAV-injected zebrafish embryos were
monitored for 5 days post infection for quantification of cumulative percent
survival (A) and viral burden (B). The results represent three separate
experiments. (A) Cumulative percentage survival of zebrafish infected at 48
hpf with IAV APR8 or X-31 (n=50 fish per treatment). Significantly fewer
zebrafish survived in either IAV-infected group compared with controls
(***P<0.001). (B) Quantification of viral burden in zebrafish infected with
APR8 or X-31 (n=20 fish per treatment). Viral burden increases 10- to 20-fold
in APR8- or X-31-infected zebrafish. In APR8-infected embryos, viral burden
increased steadily over time through to 96 hpi. In X-31-infected zebrafish,
viral burden peaked around 48 hpi. These data demonstrate IAV replicates
within zebrafish and suggest that death in IAV-infected zebrafish is likely to
be caused by infection with the virus.
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virus and a lack of localized secondary bacterial infection. Taken
together, these pathology analyses of IAV-infected zebrafish show
edema and tissue destruction, which is consistent with a primary
systemic influenza infection with multiple organ involvement.
In vivo imaging reveals infection dynamics
In addition to the isolation of the innate immune response in
zebrafish embryos and larvae, early-life stage zebrafish are also
optically transparent and can be used for in vivo microscopy studies.
A genetically modified strain of IAV has been engineered
previously, in which green fluorescent protein (GFP) is fused to the
NS1 segment of APR8 (named NS1-GFP) (Manicassamy et al.,
2010). GFP is therefore not incorporated into IAV virus particles,
and thus GFP expression reflects viral infection and replication
because GFP will only be expressed in the infected cells in which
NS1 is translated. To visualize IAV infection dynamics and cell
tropism in vivo, NS1-GFP was injected into the DC of 2-dpf
zebrafish. Infection dynamics were monitored over time through
confocal fluorescence microscopy. At 48 hpi, the time at which
histopathology analysis was performed, NS1-GFP infection caused
mild heart edema and fluorescence was observed in the yolk sac,
heart and other locations throughout the head, trunk and tail
(Fig. 5C,D). Zebrafish injected with PBS exhibited background
levels of autofluorescence, but did not recapitulate the punctate
fluorescence pattern seen in NS1-GFP-infected zebrafish (compare
Fig. 5A,B with Fig. 5C,D). DC injection of NS1-GFP most
consistently resulted in fluorescence in cells of the cardiovascular
system, including the heart (Fig. 5C and inset) and blood vessels
(Fig. 5E and inset). The fluorescence pattern observed was
reminiscent of fli1-promoter-driven expression (endothelium
specific) (Lawson and Weinstein, 2002), suggesting that DC
injection of IAV results in infection of vascular endothelial cells in
zebrafish. IAV is known to infect cultured human lung
microvascular endothelial cells (Armstrong et al., 2012), thus
supporting that IAV cell tropism might be conserved between
zebrafish and humans.
In humans, IAV infection can lead to viremia, but IAV more
commonly infects epithelial cells of the upper and lower respiratory
tract. Zebrafish do not possess the equivalent of a mammalian lung,
but the swimbladder is considered to be an anatomically and
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Fig. 2. ifnφ1 and mxa mRNA expression is upregulated in
IAV infected zebrafish. Results from qPCR experiments where
ifnφ1 and mxa expression is normalized to 18S mRNA. The
data presented represent three individual experiments, n=10
fish per treatment. Each bar represents the mean fold induction
of IAV-infected samples compared with corresponding controls.
(A,B) ifnφ1 transcripts were upregulated 8- to 12-fold in APR8-
infected zebrafish, with the peak transcript level occurring at 48
hpi. (C) mxa expression was upregulated 5- to 6-fold with
expression steadily increasing in APR8-infected zebrafish
through to 72 hpi, and (D) peak expression occurred in X-31-
infected zebrafish at 48 hpi. These data suggest that antiviral
signaling is elicited in IAV-infected zebrafish.
Fig. 3. IAV infection causes a disease phenotype in
zebrafish. Brightfield microscopy of live zebrafish at 24, 48 and
72 hpi, side oriented, anterior left, dorsal top, magnification ×25.
The data presented represent three individual experiments, a
mean of n=7 fish per treatment. (A,C,E) PBS-injected controls.
Development proceeded normally in PBS-injected controls at 24
hpi (A), 48 hpi (C) and 72 hpi (E). (B,D,F) APR8-infected
zebrafish. Embryos infected with APR8 or X-31 (data not shown)
displayed symptoms of infection. IAV-infected zebrafish had
pericardial edema (black arrowheads in B,D,F) and yolk sac
edema (white arrowheads in B,D,F). IAV-infected zebrafish also
had craniofacial abnormalities (red arrowhead in D) and arched
backs (red arrowhead in F). The most striking phenotype of IAV-
infected zebrafish was generalized edema that worsened over
time.
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functionally analogous organ (Robertson et al., 2007; Winata et al.,
2009; Zheng et al., 2011). A swimbladder infection model has
recently been developed for the fungal pathogen Candida albicans,
introduced through immersion (Gratacap et al., 2013) and by
injection (Brothers et al., 2013). Hence, we attempted to model a
localized, epithelial IAV infection in zebrafish by injecting IAV
directly into the swimbladder subsequent to its inflation (5 dpf).
Injection of NS1-GFP into the swimbladder resulted in dense,
punctate fluorescence in this region at 24 hpi (Fig. 5I,J), which was
not observed in PBS-injected fish (Fig. 5G,H). The ability to
visualize this fluorescent reporter strain of IAV in vivo highlights
one of the advantages of using the zebrafish model to study
infectious diseases and suggests that IAV infects cells that line
surfaces of the body (i.e. epithelia and endothelia) in zebrafish as it
does in humans.
The neuraminidase inhibitor Zanamivir confers protection
against IAV infection in zebrafish
A transparent host susceptible to IAV infection, together with the
NS1-GFP strain of IAV (Manicassamy et al., 2010), affords us the
unique opportunity to acquire in vivo data about potential test
compounds that could disrupt infection progression. Zebrafish have
been utilized for many high-throughput drug screens (Taylor et al.,
2010), and because IAV rapidly mutates and becomes resistant to
antivirals, a zebrafish model of human IAV infection will be
invaluable for testing the antiviral potential of chemical compounds.
As a proof-of-concept experiment, the antiviral Zanamivir was
administered to infected zebrafish in order to test whether it could
alter IAV infection. Zanamivir is a neuraminidase inhibitor that
disrupts viral exit from infected cells and has known antiviral
activity against influenza A and B viruses. Zanamivir was
administered through immersion at clinically relevant doses (16.7 or
33.3 ng/ml) twice daily, beginning at 3 hpi (when GFP expression
is first observed near to the injection site in NS1-GFP-infected
zebrafish). GFP expression was monitored and documented by using
confocal microscopy, and both behavior and gross pathology were
assessed. Treatment with either dose of Zanamivir did not alter
behavior or the overall phenotype in PBS-injected controls (data not
shown). NS1-GFP-infected zebrafish that had been treated with
either dose of Zanamivir were more mobile, more likely to undergo
the normal transition from a side-laying to upright orientation and
displayed reduced pericardial and yolk sac edema compared with
untreated infected zebrafish (data not shown, compare Fig. 6B,C
with Fig. 6A). Confocal imaging of GFP expression in NS1-GFP
infected zebrafish with and without Zanamivir treatment revealed
that both doses of Zanamivir reduced GFP expression in the body
1231
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Fig. 4. Histopathology of zebrafish infected with IAV. Parasagittal semi-thin sections from PBS-, APR8- or X-31-injected zebrafish at 48 hpi, stained with
Toluidine Blue (n=3 per group, 350 sections per fish). Anterior to the left, dorsal top. PBS control (A-D), APR8-infected (E-H) and X-31-infected (I,J) zebrafish.
(B) Head kidney (hk), liver (lv) and yolk sac (ys) of a control zebrafish. No degeneration of cells was observed. (C) Gill and pharyngeal arches adjoined to the
occipital region of a control zebrafish. All tissues are without pathological anomalies: semicircular canal of the inner ear (scc) with macula (mc), cartilage of fifth
pharyngeal arch (pa) and anterior located gill filaments (gf). (D) The same control fish with healthy heart in front of the yolk sac, atrium (at), ventricle (vt), conus
ateriosus (ca) and pericardial volume (pc). (F) The liver of APR8-infected zebrafish. The white arrowheads indicate the presence of degenerative liver tissue,
indicated by the necrotic disintegration of nuclei. (G) Gill chamber of APR8-infected zebrafish. The white arrowheads indicate necrotic gill filaments that contain
many vacuolated cells. (H) Heart region of APR8-infected zebrafish. The white arrowhead indicates the fluid-filled pericardium. The histological analysis
confirms the edema seen in IAV-infected zebrafish (Fig. 3B,D,F). (J) The head kidney of X-31-infected zebrafish shows clear signs of necrotic tissue
degeneration. The white arrowheads indicate the presence of degenerating cells in the hematopoietic part of the head kidney.
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of larval zebrafish (Fig. 6B1,C1) compared with infected untreated
zebrafish (Fig. 6A1), but did not visibly inhibit GFP expression in
the yolk region (Fig. 6A1-C1). Although the mortality of PBS-
injected zebrafish was not significantly altered by either dose of
Zanamivir, NS1-GFP infection significantly increased mortality
compared with PBS-injected groups. Both doses of Zanamivir
significantly rescued the mortality of NS1-GFP-infected zebrafish
(Fig. 6D). The results of these experiments demonstrate that a
compound with established antiviral activity in humans has similar
activity in zebrafish and reinforce the validity of utilizing this model
for chemical screens to identify novel anti-influenza compounds.
DISCUSSION
Influenza infections are a threat to human and animal health, as well
as to the global economy. Despite annual influenza vaccines and
decades of research, influenza still causes substantial morbidity and
mortality worldwide. Influenza research using animal models is
crucial for the introduction of new antiviral drugs that are effective
against viruses resistant to current antiviral treatments. These models
also enhance our understanding of the host signaling pathways and
defense systems that alleviate or exacerbate disease. Here, the first
studies using zebrafish as a model system for human IAV research
are presented. Infection of zebrafish embryos with IAV is
demonstrated, and the subsequent antiviral signaling and pathology
are characterized. Injection of IAV into the bloodstream results in
increased viral burden and mortality compared with uninfected
controls. Cytokine profiles show that antiviral signaling is induced
in IAV-infected zebrafish. Gross pathology and histopathology
reveal typical symptoms of influenza. Infection with a GFP reporter
strain of IAV enables visualization of infected cells in vivo, and GFP
expression and mortality can be ameliorated by antiviral treatment,
supporting the relevance of this model for antiviral drug screening.
Owing to the optical clarity of zebrafish embryos and their potential
for high-throughput genetic and drug screening, this zebrafish
embryo model of IAV infection will be an important resource for
dissecting molecular mechanisms of host-pathogen interactions in
vivo, as well as for identifying new antiviral therapies.
Implications for the presence of α-2,6-linked sialic acids in
zebrafish embryos
Certain characteristics of the zebrafish model system make it an
attractive option for infectious disease research. To date, no naturally
occurring viral infections of zebrafish have been reported (Crim and
Riley, 2012). It has been shown that zebrafish can be infected with
many fish-specific viruses (LaPatra et al., 2000; Sanders et al., 2003;
Phelan et al., 2005; Novoa et al., 2006; Lu et al., 2008; Xu et al.,
2008; Encinas et al., 2010), and there may be an untapped potential
for zebrafish to host human viral pathogen infections. One objective
of this study was to determine whether zebrafish embryos could
serve as a host for infection with mammalian and/or human isolates
of IAV. A necessary prerequisite for human IAV infection is the
presence of α-2,6-linked sialic acid modifications on host
glycolipids or glycoproteins. IAV hemagglutinin spikes bind to host
sialic acids, and viruses enter host cells through receptor-mediated
endocytosis. Because human IAV preferentially binds to α-2,6-
linked sialic acids, an analysis of the sialic acid linkage types present
in zebrafish embryos was conducted. High performance anion
exchange chromatography with pulsed amperometric detection
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Fig. 5. NS1-GFP shows infection of the zebrafish
cardiovascular system and swimbladder. (A-D) Single focal
planes of PBS- or NS1-GFP-injected, fixed casper mutant
zebrafish at 48 hpi, side mounted, anterior left, dorsal top, ×4
magnification. (A) Fluorescence micrograph of a PBS-injected
control showing background autofluorescence. The data
presented represent three individual experiments, a mean of
n=6 fish per treatment. (B) Panel of PBS control showing
merged fluorescence and brightfield micrographs.
(C) Fluorescence micrograph of NS1-GFP-infected zebrafish.
Punctate fluorescence confirms viral replication. Inset is a
computer magnification of the pericardial region. White
arrowhead points to fluorescence in the heart. (D) Merge of
NS1-GFP-infected embryo fluorescence and brightfield
micrographs. (E,F) 3D reconstruction of NS1-GFP-infected, live
zebrafish, 24 hpi, side mounted, anterior left, dorsal top,
magnification ×10. Punctate fluorescence was observed in major
blood vessels. Inset is a computer zoom of two infected blood
vessels. White arrowhead denotes fluorescence in an
intersomitic blood vessel. (G-J) 3D reconstruction of casper
mutant zebrafish after injection of either PBS or NS1-GFP into
the swim bladder at 5 dpf, fixed at 24 hpi, side mounted, anterior
left, dorsal top. (G) Fluorescence micrograph of zebrafish with
PBS injected into the swim bladder, the image shows
background autofluorescence. The data represent two individual
experiments, a mean of n=5 fish per treatment. (H) Merged
panel of PBS-injected control fluorescence and brightfield
micrographs. (I) Fluorescence micrograph of NS1-GFP swim
bladder infection. Green punctate fluorescence is likely to show
infection of epithelial cells around the swim bladder.
(J) Fluorescence and brightfield micrograph merge for NS1-GFP
swim bladder infection. Infection with the NS1-GFP reporter
virus in transparent zebrafish larva allows for visualization of
viral replication, spread, resolution of infection and cell tropism in
vivo.
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(HPAEC-PAD) analysis demonstrated that α-2,6-linked sialic acids
are present in 2-dpf zebrafish embryos. Terminally linked sialic
acids can occur in α-2,3, α-2,6, or α-2,8 linkages. α-2,6- but not α-
2,3-linked sialic acids were detected in zebrafish embryos at 2 dpf.
We did not attempt to detect α-2,8-linked sialic acids in our sample;
however, others have previously demonstrated that zebrafish
synthesize a variety of sialylated glycoconjugates during the early
stages of development (Marx et al., 2001; Chang et al., 2010;
Dehnert et al., 2012; Langhauser et al., 2012; Schaper et al., 2012).
Identification of the sialic acid linkages present at different
developmental stages, including juvenile and adult zebrafish, will
further inform which human viral diseases could potentially be
studied using the zebrafish model. The presence of α-2,6-linked
sialic acids in zebrafish embryos suggests that this model organism
might be able to support infection with other pathogens that also
bind to α-2,6-linked sialic acids. Examples of additional pathogens
that bind to α-2,6-linked sialic acids include certain members of the
Coronaviridae, Paramyxoviridae, Caliciviridae, Picornaviridae,
Reoviridae, Polyomaviridae, Adenoviridae and Parvoviridae virus
families (Neu et al., 2011; Matrosovich et al., 2013).
In addition to requirements for certain cellular receptors, another
important factor to consider in zebrafish infection studies is the
optimal incubation temperature for viruses. Zebrafish can be grown
in a temperature range within that of the human respiratory tract
(from 25 to 33°C). Thus, zebrafish might be well suited to modeling
human respiratory viral infections, especially given the similarities
between the zebrafish swimbladder and the human lung (Robertson
et al., 2007; Winata et al., 2009; Zheng et al., 2011; Gratacap et al.,
2013), and recent demonstrations of infection of the zebrafish
swimbladder with a human fungal pathogen (Gratacap et al., 2013).
Advantages to using zebrafish for infection studies
Modeling infections in zebrafish of all life stages has added insights
into host-pathogen interactions in vivo (Dooley and Zon, 2000;
Trede et al., 2004; Sullivan and Kim, 2008; Kanther and Rawls,
2010). Some pathogens can be transmitted to zebrafish embryos or
adults through immersion, whereas others must be injected.
Immersion of zebrafish embryos in egg media containing 7×106
EID50 IAV did not result in infection (data not shown). We have not
yet attempted to immerse or inject adult zebrafish with IAV. The
zebrafish embryo infectious disease model has certain advantages
that will be valuable for IAV studies, including temporal segregation
of innate and adaptive immunity, amenability to genetic
manipulation, optical transparency and the potential for high-
throughput chemical screens. Some of these advantageous
characteristics carry over into adult zebrafish, and the study of IAV
infection in adult zebrafish is likely to provide additional unique
experimental opportunities and insights into this infectious disease.
During zebrafish development, functionality of the innate and
adaptive arms of the immune response is temporally separated. The
innate immune response is active as early as 24 hpf; however, the
adaptive immune response is not fully functional during the first 4-
6 weeks of zebrafish development (Lam et al., 2004; Kanther and
Rawls, 2010). Therefore, zebrafish embryos provide the possibility
to study the role of innate immunity during IAV infection with little
to no interference from the adaptive immune response. The
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Fig. 6. Antiviral treatment with Zanamivir confers protection after infection in zebrafish. Zanamivir (16.7 ng/ml or 33.3 ng/ml) was administered at 3 hpi,
and Zanamivir-containing media was changed twice daily. (A-C1) Single focal planes of NS1-GFP-injected, live zebrafish at 48 hpi, side mounted, anterior left,
dorsal top, ×4 magnification. Lettered panels are brightfield images, and numbered panels are fluorescence micrographs. (A,A1) NS1-GFP-infected zebrafish.
Note fluorescence in the yolk region, as well as punctate fluorescence throughout the body. (B,B1) NS1-GFP-infected zebrafish treated with 16.7 ng/ml
Zanamivir. (C,C1) NS1-GFP-infected zebrafish treated with 33.3 ng/ml Zanamivir. Note that treatment with Zanamivir at either dose drastically reduced the
punctate fluorescence in the body of the zebrafish, whereas fluorescence in the yolk region remained despite antiviral treatment. The data presented represent
three individual experiments, a mean of n=20 fish per treatment. (D) Quantification of healthy, morbid and dead zebrafish at 5 days post infection with NS1-
GFP. These data are compiled from three independent experiments, and the number of zebrafish per treatment group is labeled on the graph. e, embryos.
Fisher’s exact test two-tailed P-values (with Bonferroni correction) were used to determine whether the proportion of dead versus alive (healthy and morbid)
zebrafish significantly differed between treatments. Addition of either dose of Zanamivir to PBS-injected controls did not significantly affect the proportion of
zebrafish that died. Infection with NS1-GFP significantly increased the proportion of dead zebrafish compared with the PBS-injected group (P=0.0018).
Addition of either dose of Zanamivir significantly decreased the proportion of NS1-GFP-infected zebrafish that died compared with the infected, untreated
group (P=0.0012 and P=0.0246 for 16.7 ng/ml and 33.3 ng/ml Zanamivir, respectively). *P<0.05, **P<0.01.
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transparency of zebrafish embryos coupled with the isolation of
innate immunity provides the unique opportunity, not possible in any
other vertebrate animal models of IAV infection, to observe
spatiotemporal dynamics of IAV infection and the innate immune
response in vivo. Infection with a fluorescent reporter strain of IAV
in a transparent host will be useful for in vivo IAV cell tropism
studies and to understand in greater detail the progression of
influenza in response to experimental manipulations. The use of
fluorescent IAV and fluorophore-labeled transgenic zebrafish lines
that enable direct visualization of phagocytes (Mathias et al., 2006;
Renshaw et al., 2006; Hall et al., 2007; Ellett et al., 2011), antiviral
signaling and/or proinflammatory signaling will allow for
visualization of interactions between pathogens and the innate
immune system in real time. Mutant lines and morpholino-mediated
protein knockdown provide opportunities to manipulate the host
response and to determine roles for gene products in the innate
immune response to IAV. Leveraging the advantages of zebrafish
embryos to isolate and dissect roles for innate immunity in the host
response to IAV infection and disease severity could be particularly
informative in light of the recent findings implicating dysregulated
innate immunity in mortalities resulting from IAV infection in
mammals (Brandes et al., 2013). Because the innate immune
response is also known to promote adaptive immunity, a better
understanding of the innate immune response to IAV infection could
potentially both reduce mortality and improve the success of current
vaccination and preventative strategies.
As zebrafish display adaptive immunity later in their
development, the model presented here could possibly be extended
to study the adaptive immune response and vaccine efficacy against
IAV infection. Unlike embryonic zebrafish, adult fish are not
optically transparent, and genetic manipulation is currently more
challenging in adults than in embryos. However, pigmentation
mutant lines of zebrafish (e.g. casper) (White et al., 2008) could
potentially allow for live imaging of fluorescent host-pathogen
interactions in adult zebrafish. Additionally, large-scale mutagenesis
projects and targeted mutagenesis technologies, such as zinc finger
nucleases (ZFN) (Meng et al., 2008), transcription activator-like
effector nucleases (TALEN) (Huang et al., 2011) and clustered
regularly interspaced short palindromic repeats (CRISPR) (Hwang
et al., 2013), are generating many new zebrafish mutant lines. These
mutant lines could then be used to assess gene function in the host
response to IAV infection and vaccine success in older zebrafish.
The ability to conduct high-throughput drug screens in embryos,
and even in adult zebrafish, is a major advantage to the use of this
vertebrate animal model for infection studies. IAV is rapidly
developing resistance to the few anti-influenza compounds available.
We have laid the foundation for use of the zebrafish embryo infection
model to screen for new anti-influenza drugs by demonstrating that
a fluorescent reporter strain of IAV infects zebrafish and that NS1-
GFP expression (i.e. viral replication and infection) in zebrafish
responds to a known anti-influenza compound as it does in humans.
Fluorescence in NS1-GFP-infected zebrafish could be used to
quantify viral burden or follow the progression of IAV infection in
vivo in response to a range of test compounds. When using animal
models to screen for potential therapeutic molecules, it is important
to balance maximal protection with minimal side effects and to
consider clinically relevant doses. This can be accomplished in
zebrafish through dose-response titration experiments and
comparison with clinically relevant dosages. The antiviral Zanamivir
is administered to humans through intravenous or oral inhalation
routes. Serum concentrations of Zanamivir were calculated in healthy
human volunteers following twice daily treatment with Zanamivir at
multiple doses used in the clinic (100, 200 or 600 mg intravenous
solution or 10 mg oral inhaled) and the maximum serum Zanamivir
concentrations reported were between 9.83 and 45.3 ng/ml (Shelton
et al., 2011). Assuming an average of 6 litres of human blood
volume, 100 or 200 mg doses of Zanamivir given intravenously
would result in ~16.7 or 33.3 ng/ml Zanamivir in the blood. We
mimicked this dose of Zanamivir in our zebrafish influenza infection
model by immersing zebrafish in 16.7 or 33.3 ng/ml Zanamivir
solutions and changing the media twice daily. Both doses of
Zanamivir significantly improved the survival of NS1-GFP-infected
zebrafish and reduced the expression of GFP in the body of the
zebrafish without reducing expression of GFP in the yolk region. The
zebrafish yolk is encased by a layer of cells that share cytoplasm,
called the yolk syncytial layer. The yolk syncytial layer is in close
proximity to the initial site of NS1-GFP infection, the DC. Therefore,
although Zanamivir administration at 3 hpi can largely prevent NS1-
GFP infection in the body of the zebrafish, it cannot prevent local
infection in the yolk syncytial layer. This proof-of-concept
experiment suggests the exciting possibility that the zebrafish embryo
model of IAV infection can be used to rapidly identify novel anti-
influenza drugs that might ultimately translate into human therapies.
Conclusion
The results of the present study further establish the zebrafish as a
valuable animal model for studying host-pathogen interactions. This
zebrafish model of human IAV infection has great potential for the
exploration of the relationships between viral and host factors that
contribute to the pathogenesis of influenza. Some of these factors
could become targets for the development of new antiviral
interventions or adjuvant therapies. A zebrafish model of IAV
infection will provide a powerful new tool in the search for new
ways to prevent and treat influenza.
MATERIALS AND METHODS
Zebrafish care and maintenance
Zebrafish (Danio rerio) used in this study were handled in accordance with
the recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The protocols used in this study
were approved by the Institutional Animal Care and Use Committee
(IACUC) at the University of Maine (Protocol Number: A2013-06-03).
Zebrafish were maintained in the Zebrafish Facility at the University of
Maine, Orono. The facility was maintained according to IACUC standards.
IACUC approved guidelines for zebrafish care followed the standard
procedures (www.zfin.org) of a 14-hour light, 10-hour dark cycle at 28°C.
Embryos were obtained by natural spawnings of adult AB or casper mutant
zebrafish. Fertilized eggs were collected and raised in egg water (60 μg/ml
Instant Ocean sea salts; Aquarium Systems, Mentor, OH) at 28°C.
Determination of total sialic acids
Analysis of the total sialic acid was performed at the Complex Carbohydrate
Research Center of the University of Georgia. Zebrafish embryos were stored
in 70% ethanol, constituting the sample matrix. The ethanol from the sample
matrix was first evaporated from each tube under a stream of nitrogen gas,
which was subsequently combined into one tube. The volume was further
reduced to between 1.0 and 1.5 ml under a stream of nitrogen gas and then
precipitated with cold acetone:water (crude protein extract). Precipitation of
the sample was performed to remove contaminants and extraneous material
of the zebrafish. A weighed amount (3.6 mg) of the dried crude protein extract
from zebrafish embryos was hydrolyzed with 2 M acetic acid to liberate sialic
acids from glycoproteins. After hydrolysis, the sample was dried under a
stream of air, re-dissolved in cold water, sonicated for 5 minutes and then
transferred into an injection vial. A mixture of standards for sialic acids at
known concentrations was subjected to hydrolysis conditions under identical
conditions to those used for the samples.
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The sialic acids were analyzed by HPAEC-PAD using a Dionex ICS3000
system equipped with a gradient pump, an electrochemical detector and an
autosampler. The individual sialic acids were separated by a Dionex
CarboPac PA20 (3×150 mm) analytical column with an amino trap. The
gradient program used the following mobile phase eluents: 100 mM NaOH,
and 1M sodium acetate in 100 mM NaOH. Injections were made every 35
minutes. All methods were based on protocols described previously by
Hardy and Townsend (Hardy and Townsend, 1994). Four concentrations of
the standard mixture were prepared by serial dilution to establish a
calibration equation. The number of moles of each residue in the sample was
quantified by linear interpolation from the calibration equation.
Determination of α-2,3-and -2,6-linked sialic acids
A weighed amount (~4.16 mg) of the dried crude protein extract from
zebrafish embryos was prepared for an experiment to determine and quantify
α-2,3- and -2,6-linked sialic acids. The sample was first digested with
trypsin and chymotrypsin for 24 hours to release glycopeptides. The digest
was passed through a C18 Sep-Pak Vac 1cc (50 mg) cartridge (Waters
Corporation, Milford, MA) for purification, and the glycopeptides were
eluted and lyophilized. The glycopeptides were subsequently treated with
sialidase specific to cleavage of α-2,3-linked sialic acids. The digest was
passed through a C18 Sep-Pak Vac 1 cc (50 mg) cartridge (Waters
Corporation, Milford, MA) and α-2,3-linked sialic acids were eluted with
5% acetic acid, and remainder glycopeptides were eluted into a separate
tube, lyophilized and finally treated with general neuraminidase to release
α-2,6-linked and all remaining sialic acids from the glycoprotein.
A mixture of standards for sialic acids at known concentrations was
prepared and not hydrolyzed at the same time as the samples were treated.
The sialic acids in the sample and in the standard mixture were analyzed by
HPAEC-PAD as described above. Four concentrations of the standard
mixture were prepared by serial dilution to establish a calibration equation.
The number of moles of each residue in the sample was quantified by linear
interpolation from the calibration equation.
Microinjection of IAV
Embryos were manually dechorionated at 48 hpf with fine forceps (DuMont
no. 5). Prior to injections, fish were anesthetized in tricaine solution and
lined up on a 3% agarose gel in a Petri dish before being injected into the
DC with 1.5 nl (~5×103 EID50) of APR8 or X-31 IAV or 4 nl [~6×102
plaque forming units (PFU) per embryo] of NS1-GFP in PBS with a final
concentration of 0.25% phenol red. Dechorionated 5-dpf zebrafish with
inflated swimbladders were anesthetized, and fish were injected as above
with NS1-GFP in the posterior part of the swimbladder. Sterile PBS
including 0.25% phenol red was injected into the DC or swimbladder of
control zebrafish. Following injection, zebrafish were maintained at 33°C
and the egg water was changed daily. Microinjection was controlled by an
MPPI-2 pressure microinjector (Applied Scientific Instruments) and pulled
microcapillary pipettes (Sutter Instruments, Novato, CA) were used to inject
the virus or PBS.
Cell culture
Madin-Darby canine kidney (MDCK) cells were purchased from ATCC
(CCL-34) and cultured at 37°C under 5% CO2. MDCK cells were
maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% heat-inactivated fetal bovine serum, 1% antibiotics (100 units/ml
penicillin and 100 μg/ml streptomycin) and 1% L-glutamine (2 mM). All cell
culture media was purchased from GIBCO Life Technologies.
Virus, mortality curves and viral burden assays
The influenza viral strains H1N1 (APR8/34, part no. 490710) and H3N2 (X-
31 A/Aichi/68, part no. 490715) were purchased from Charles River
Laboratories (North Franklin, CT). The virus strains were stored at −80°C,
thawed at room temperature and diluted in sterile PBS to the desired
infectious dose.
Wild-type zebrafish embryos were injected and maintained as described
above. For mortality experiments, water was changed daily and mortality
was monitored and counted from 24-96 hpi.
Viral titer of influenza virus in zebrafish was quantified using a TCID50
end point dilution assay. Viral burden assays were performed in MDCK
cells. For viral burden assays, 20 fish were collected immediately following
injection (0 hpi) and then between 24 and 96 hpi at 24-hour intervals. Water
was changed daily and dead fish were removed prior to collection at each
time point. Embryos were homogenized in DMEM (GIBCO Life
Technologies, Carlsbad, CA) supplemented with 25 mM HEPES, 0.2%
BSA, 100 units/ml penicillin and 100 μg/ml streptomycin. Homogenates
were centrifuged at 15,000 g at 4°C for 10 minutes. Supernatants were
removed in two aliquots of 105 μl and frozen at −80°C before the TCID50
assay.
MDCK cells were plated 24 hours prior to the assay in 96-well plates
(Corning Incorporated, Corning, NY) such that the wells were ~70%
confluent at the time of virus addition. For MDCK cells, 100 μl of cell
suspension (~15,000 cells) was added to each well of a 96-well plate. At the
time of the assay, virus-containing supernatants were thawed and
immediately serially diluted in dilution media (unsupplemented Eagle’s
minimal essential medium for MDCK cells) prior to use in TCID50 assays.
Cells were overlaid with 100 μl of virus dilution per well and incubated for
2 hours at 37°C under 5% CO2. Immediately following the 2-hour
incubation period, an additional 100 μl of dilution media was added, and
plates were covered with adhesive sealing film (Excel Scientific, Victorville,
CA) and returned to 37°C under 5% CO2. For all assays, uninfected wells
were maintained as controls. Cytopathic effects (CPE) were observed after
3 days. TCID50/ml was calculated according to the Reed-Muench method.
Each bar in the graph shows a representative experiment of TCID50/ml
values. Three independent experiments were performed. Error bars were
calculated as s.e.m.
Zanamivir treatment
Zanamivir (AK Scientific, Union City, CA) was dissolved in nuclease-free
water to 10 mg/ml, aliquoted and frozen at −20°C. NS1-GFP-and PBS-
injected zebrafish were kept in 60-mm Petri dishes at a density of 20-25
zebrafish per dish in 10 ml of egg water at 33°C. At 3 hpi, egg water was
removed and replaced with egg water containing 0, 16.7 or 33.3 ng/ml
Zanamivir. Egg water with the desired concentrations of Zanamivir was
remade and replaced twice daily for 5 days post infection.
RNA extraction, cDNA synthesis and real-time PCR
Total RNA was extracted from whole embryos at 24, 48 and 72 hpi by
homogenizing 10 fish at each time point, treating with TRIzol reagent
(Invitrogen, Carlsbad, CA) and subsequently storing at −80°C. RNA was
extracted according to the manufacturer’s protocol. Reverse transcription
reactions were performed in a manner similar to those reported previously
(Phelan et al., 2005) to synthesize cDNA using Bio-Rad iScript (Bio-Rad
Laboratories, Hercules, CA). Quantitation of ifnφ1 (Aggad et al., 2009) and
mxa was performed through real-time PCR using an I-cycler IQDetection
System (Bio-Rad Laboratories, Hercules, CA). The cycling parameters used
were chosen as described previously (Phelan et al., 2005). Fluorescence
measurements were made at each cycle during the annealing step, and the
copy number was determined based on a standard curve using the iCycler
software. The value for each sample was normalized to the corresponding
18S value to determine relative copy number.
Histopathology
For the histopathological examination, zebrafish were fixed with a mixture
of 1.5% glutaraldehyde and 1.5% paraformaldehyde in 0.1 M sodium
cacodylate (pH 7.4) buffer containing 0.001% CaCl2, they were
subsequently rinsed in 0.1 M sodium cacodylate buffer containing 10%
sucrose. Postfixation staining of membrane lipids was performed in 1%
OsO4 that had been dissolved in 0.1 M sodium cacodylate buffer
containing 8% sucrose, staining was performed for 2 hours at room
temperature. Subsequently, specimens were embedded in Epon epoxy
resin. Specimens of all experimental groups were serial semi-thin cross-
sectioned and serial semi-thin parasagittal sectioned (1 μm, Reichert
Ultracut microtome), stained with Toluidine Blue and mounted in 
DPX.
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Imaging
A Zeiss stereomicroscope running Axiovision software was used to obtain
the time course of gross pathology images. A Zeiss Imager-Z compound
microscope and Axiovision software was used for the histopathological
analysis. An Olympus Fluoview IX-81 inverted microscope with FV1000
confocal system was used for fluorescence and brightfield imaging of PBS-
injected or NS1-GFP-infected embryos. Images were obtained using the ×4
[0.16 numerical aperture (NA), Olympus] or ×10 (0.4 NA, Olympus)
objectives.
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